Literature DB >> 12401529

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

Simon Stewart1, Carole L Hart, David J Hole, John J V McMurray.   

Abstract

PURPOSE: To describe the effect of atrial fibrillation on long-term morbidity and mortality. SUBJECTS AND METHODS: The Renfrew/Paisley Study surveyed 7052 men and 8354 women aged 45-64 years between 1972 and 1976. All hospitalizations and deaths occurring during the subsequent 20 years were analyzed by the presence or absence of atrial fibrillation at baseline. Lone atrial fibrillation was defined in the absence of other cardiovascular signs or symptoms. Cox proportional hazards models were used to adjust for age and cardiovascular conditions.
RESULTS: After 20 years, 42 (89%) of the 47 women with atrial fibrillation had a cardiovascular event (death or hospitalization), compared with 2276 (27%) of the 8307 women without this arrhythmia. Among men, 35 (66%) of 53 with atrial fibrillation had an event, compared with 3151 (45%) of 6999 without atrial fibrillation. In women, atrial fibrillation was an independent predictor of cardiovascular events (rate ratio [RR] = 3.0; 95% confidence interval [CI]: 2.1-4.2), fatal or nonfatal strokes (RR = 3.2; 95% CI: 1.0-5.0), and heart failure (RR = 3.4; 95% CI: 1.9-6.2). The rate ratios among men were 1.8 (95% CI: 1.3-2.5) for cardiovascular events, 2.5 (95% CI: 1.3-4.8) for strokes, and 3.4 (95% CI: 1.7-6.8) for heart failure. Atrial fibrillation was an independent predictor of all-cause mortality in women (RR = 2.2; 95% CI: 1.5-3.2) and men (RR = 1.5; 95% CI: 1.2-2.2). However, lone atrial fibrillation (which occurred in 15 subjects) was not associated with a statistically significant increase in either cardiovascular events (RR = 1.5; 95% CI: 0.6-3.6) or mortality (RR = 1.8; 95% CI: 0.9-3.8).
CONCLUSIONS: Atrial fibrillation is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality, especially in women.

Entities:  

Mesh:

Year:  2002        PMID: 12401529     DOI: 10.1016/s0002-9343(02)01236-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  397 in total

1.  Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study.

Authors:  Rachel R Huxley; Alvaro Alonso; Faye L Lopez; Kristian B Filion; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; James S Pankow; Elizabeth Selvin
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

2.  Atrial fibrillation: an emerging epidemic?

Authors:  J S Steinberg
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

3.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

4.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

Review 5.  Oral Anticoagulation.

Authors:  Ertunc Altiok; Nikolaus Marx
Journal:  Dtsch Arztebl Int       Date:  2018-11-16       Impact factor: 5.594

6.  Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?

Authors:  Marek Pizon; Norbert Friedel; Monika Pizon; Miriam Freundt; Michael Weyand; Richard Feyrer
Journal:  J Cardiothorac Surg       Date:  2013-11-28       Impact factor: 1.637

7.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.

Authors:  Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Adrian F Hernandez; Allan J Walkey; Emelia J Benjamin; Lesley H Curtis; Susan R Heckbert
Journal:  Eur Heart J       Date:  2013-11-25       Impact factor: 29.983

Review 8.  Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation.

Authors:  Robert M A van der Boon; Patrick Houthuizen; Rutger-Jan Nuis; Nicolas M van Mieghem; Frits Prinzen; Peter P T de Jaegere
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

Review 9.  [Radiofrequency current or cryoballoon for ablation of atrial fibrillation? : Hot or cold?]

Authors:  B Reissmann; K-H Kuck; A Metzner
Journal:  Herz       Date:  2017-06       Impact factor: 1.443

Review 10.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.